About Integration of Viatris’ Biocon’s subsidiary — Biocon Biologics has completed the Integration of Viatris’ Biosimilar Business in 31 Countries in Europe. Following the acquisition of substantially all of the global biosimilar business of Viatris in November 2022, and the related integration of over 70 emerging market countries in July 2023 and North America in …